Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The European Commission has launched an investigation into claims that drug company Aspen Pharma excessively increased prices of five life-saving cancer medicines.
The drugs include chlorambucil and busulfan - used to treat leukaemia.
The Commission said it was looking at claims that Aspen imposed "very significant and unjustified" price hikes.
The company confirmed an investigation was under way.
Patents expired
In a statement, Aspen said it was not currently in a position to comment on the proceedings but that it took compliance and competition laws very seriously and would work constructively with the EC.
Investigators will look closely at the pricing of key medical ingredients such as melphalan, mercaptopurine and tioguanine, used to treat cancers of the blood and immune systems.
http://www.bbc.co.uk/news/health-39933916
The drugs include chlorambucil and busulfan - used to treat leukaemia.
The Commission said it was looking at claims that Aspen imposed "very significant and unjustified" price hikes.
The company confirmed an investigation was under way.
Patents expired
In a statement, Aspen said it was not currently in a position to comment on the proceedings but that it took compliance and competition laws very seriously and would work constructively with the EC.
Investigators will look closely at the pricing of key medical ingredients such as melphalan, mercaptopurine and tioguanine, used to treat cancers of the blood and immune systems.
http://www.bbc.co.uk/news/health-39933916